ANGPT2 and uveitis: Further evidence on benefits of dual Ang-2/VEGF-A inhibition was obtained from a mouse model of endotoxin-induced uveitis, in which dual Ang-2/VEGF-A inhibition with a bispecific anti–Ang-2/anti–VEGF-A antibody attenuated inflammatory response by reducing leucocyte infiltration into the inner retina versus untreated controls (P < 0.00001) or anti–VEGF-A alone (P < 0.0086) [47].